Abstract
The Target of Rapamycin kinase Complex I (TORC1) is a master regulator of cell growth and metabolism in eukaryotes. Studies in yeast and human cells have shown that nitrogen/amino acid starvation signals act through Npr2/Npr3 and the small GTPases Gtr1/Gtr2 (Rags in humans) to inhibit TORC1. However, it is unclear how other stress and starvation stimuli inhibit TORC1, and/or act in parallel with the TORC1 pathway, to control cell growth. To help answer these questions, we developed a novel automated pipeline and used it to measure the expression of a TORC1-dependent ribosome biogenesis gene (NSR1) during osmotic stress in 4700 Saccharomyces cerevisiae strains from the yeast knock-out collection. This led to the identification of 440 strains with significant and reproducible defects in NSR1 repression. The cell growth control and stress response proteins deleted in these strains form a highly connected network, including 56 proteins involved in vesicle trafficking and vacuolar function; 53 proteins that act downstream of TORC1 according to a rapamycin assay—including components of the HDAC Rpd3L, Elongator, and the INO80, CAF-1 and SWI/SNF chromatin remodeling complexes; over 100 proteins involved in signaling and metabolism; and 17 proteins that directly interact with TORC1. These data provide an important resource for labs studying cell growth control and stress signaling, and demonstrate the utility of our new, and easily adaptable, method for mapping gene regulatory networks.
Keywords: TORC1, osmotic stress, yeast knock-out collection, high-throughput screen
The Target of Rapamycin (TOR) kinases are conserved across eukaryotes, where they act as master regulators of cell growth and metabolism (Loewith and Hall 2011; Laplante and Sabatini 2012). In line with their central role in cell signaling, TOR kinases respond to an enormous array of stimuli and control the activity of hundreds of proteins—functions that are supported in part by their recruitment into two distinct complexes: TOR Complex 1 (TORC1), and TOR Complex 2 (TORC2) (Barbet et al. 1996; Kim et al. 2002; Loewith et al. 2002; Urban et al. 2007; Huber et al. 2009; Soulard et al. 2010; Hsu et al. 2011). TORC1, unlike TORC2, is rapamycin sensitive, and in Saccharomyces cerevisiae is made up of the TOR kinase Tor1 (and, in its absence, the homolog Tor2), the key regulator Kog1, and two poorly characterized proteins, Lst8 and Tco89 (Heitman et al. 1991; Loewith et al. 2002; Reinke et al. 2004).
In the presence of adequate nutrients, TORC1 drives growth by activating multiple steps in protein and ribosome synthesis. First, TORC1 directly phosphorylates and activates the transcription factor Sfp1, and the AGC kinase Sch9 (Urban et al. 2007; Lempiainen et al. 2009). Sch9, in turn, then phosphorylates and blocks the activity of the transcriptional repressors Dot6, Tod6, and Stb3, leaving Sfp1 to promote the high level expression of 400 genes involved in ribosome biogenesis (Ribi), and translation (Jorgensen et al. 2004; Marion et al. 2004; Liko et al. 2007; Lippman and Broach 2009; Huber et al. 2011). Second, TORC1 acts in cooperation with Yak1 and the cAMP dependent protein kinase (PKA) pathway, to promote the activity of Fhl1, and upregulate expression of the ribosome protein (RP) genes (Martin et al. 2004; Schawalder et al. 2004; Wade et al. 2004). Third, TORC1-Sch9 phosphorylates and regulates the kinase Maf1, and other factors, to activate Pol I and Pol III, and thus rRNA and tRNA synthesis (Upadhya et al. 2002; Huber et al. 2009; Lee et al. 2009). Finally, TORC1 promotes translation, in part by blocking phosphorylation of eIF2 (Barbet et al. 1996; Loewith and Hall 2011).
In contrast, when cells are starved for energy, amino acids, or nitrogen, or exposed to noxious stress, TORC1 signaling is inhibited, leading to downregulation of Ribi and RP gene expression, rRNA and tRNA synthesis, and consequently cell growth (Powers and Walter 1999; Gasch et al. 2000; Urban et al. 2007; Brauer et al. 2008). In particular, dephosphorylation of Dot6, Tod6, and Stb3 triggers recruitment of the Class I histone deacetylase Rpd3L to the Ribi and RP genes, leading to a rapid decrease in gene expression levels (Alejandro-Osorio et al. 2009; Lippman and Broach 2009; Huber et al. 2011).
The mechanisms underlying TORC1 inhibition in nitrogen and amino acid starvation conditions are starting to come into focus. Specifically, it is now clear that nitrogen and amino acid starvation trigger activation of the GAP Npr2-Npr3-Iml1 SEAC subcomplex, SEACIT, and this in turn alters the GTP binding state of the small GTPases, Gtr1/Gtr2 (Kim et al. 2008; Sancak et al. 2008; Binda et al. 2009; Neklesa and Davis 2009; Panchaud et al. 2013). Gtr1/Gtr2 then bind TORC1 on the vacuolar membrane, and inhibit TORC1-dependent phosphorylation of Sfp1 and Sch9 (Urban et al. 2007; Binda et al. 2009; Lempiainen et al. 2009; Panchaud et al. 2013). At the same time, an interaction between Gtr1/Gtr2, the small GTPase Rho1, and TORC1 promotes release of Tap42 from the TOR complex, triggering Tap42-PP2A-dependent reprogramming of nitrogen and amino acid metabolism (Cardenas et al. 1999; Duvel et al. 2003; Yan et al. 2006; Yan et al. 2012). At least in humans, Gtr1/Gtr2 signaling also depends on interactions with the vacuolar ATPase (V-ATPase) and amino acid transporters on the vacuolar membrane (Zoncu et al. 2011; Wang et al. 2015).
Outside of nitrogen and amino acid starvation conditions, however, very little is known about TORC1, and TORC1 pathway, regulation. Npr2/Npr3, Gtr1/Gtr2, and Rho1 play little-to-no role in transmitting glucose starvation, osmotic stress, heat stress and oxidative stress signals to TORC1-Sch9 (Binda et al. 2009; Hughes Hallett et al. 2014). Instead, the AMP-activated protein kinase Snf1 partially inhibits TORC1, and/or TORC1-Sch9, signaling during glucose/energy starvation, while the MAPK Hog1 plays a small role in regulating TORC1, and/or TORC1-Sch9, signaling in osmotic stress (Hughes Hallett et al. 2014). It is also known that TORC1 binds to stress granules during heat shock, but this interaction is not required for the initial stages of TORC1 inhibition (Takahara and Maeda 2012). Thus, most of the proteins and pathways that regulate TORC1 and/or TORC1-Sch9 signaling in noxious stress and energy starvation remain to be identified.
It is also unclear how the TORC1 pathway cooperates with other signaling pathways to regulate cell growth. Numerous studies have shown that the ras/PKA pathway regulates expression of the cell growth genes in glucose, primarily by acting in parallel with Sch9 to phosphorylate and regulate Sfp1 and Dot6/Tod6 (Jorgensen et al. 2004; Marion et al. 2004; Martin et al. 2004; Zurita-Martinez and Cardenas 2005; Slattery et al. 2008; Lippman and Broach 2009). It is also known that the inositol kinases Vip1 and Kcs1, and the inositol pyrophosphates they produce, act in parallel with TORC1 to regulate Rpd3L, and thus the Ribi and RP genes, during stress (Worley et al. 2013). However, it is unclear how Kcs1 and Vip1 are regulated and if/how other pathways cooperate with TORC1 to control cell growth.
Therefore, to push our understanding of TORC1 signaling and cell growth control forward, we carried out a screen to identify proteins that are required for the downregulation of Ribi gene expression in osmotic stress. Similar screens have been carried out previously to identify proteins involved in the Unfolded Protein Response (UPR), Heat shock factor 1 (Hsf1) response (in log growth conditions), and the amino acid starvation response—in each case using a GFP reporter placed under a relevant promoter (Jonikas et al. 2009; Neklesa and Davis 2009; Brandman et al. 2012). However, a GFP reporter cannot easily be used to study cell growth control since Ribi and RP genes are only transiently downregulated during stress, leading to relatively small (twofold) changes in Ribi and ribosome protein levels (Gasch et al. 2000; Lee et al. 2011). To get around this problem, we developed a novel automated pipeline that directly measures mRNA levels at the peak of the osmotic stress response (a 32-fold change in gene expression), and used it to measure Ribi gene expression in 4700 strains from the yeast knock-out (YKO) collection (Winzeler et al. 1999). This led to the identification of 440 strains with a reproducible and highly significant (P < 0.001) defect in Ribi gene repression during stress. We then went on to show that 53 of these strains also have a significant defect in the response to rapamycin, and are therefore missing genes that act downstream of TORC1.
Among the genes that act downstream of TORC1, we find numerous factors involved in transcription and chromatin remodeling including six subunits of Rpd3L, three subunits of the Elongator complex, three histone proteins, two histone demethylases, and components of the SWI/SNF, INO80 and CAF-1 chromatin remodeling complexes. We also identified 21 ribosome proteins and translation factors in the screen, nine of which act downstream of TORC1. Other genes in the growth control network have a wide variety of functions, but include 56 proteins involved in vacuolar function and vesicle transport, including 10 components of the V-ATPase, as well as five kinases, five methyltransferases, and nine membrane transporters. Finally, 17 genes in the network physically interact with TORC1, suggesting that we have identified numerous direct regulators and effectors of TORC1 signaling.
Overall, the data presented here provide a valuable resource for labs studying TORC1 signaling, cell growth control, or the environmental stress response, and demonstrate the utility of our novel and easily adaptable method for mapping gene regulatory networks in yeast and other organisms.
Materials and Methods
Automated pipeline
Inoculation, growth, treatment, and RNA isolation steps were performed on a Biomek FX liquid handling robot (Beckman Coulter) equipped an integrated plate hotel (Cytomat) and shaking incubator (Liconic). All 96-well plates were labeled with barcodes, and loaded onto the Biomek using a barcode scanner, to ensure that the plates remained in order and maintained their original orientation. OD600 measurements were taken with a plate reader (BioTek Synergy 2) in sterile 96-well plates (Greiner Bio-One) at 30°. Detailed descriptions of the protocols run on the Biomek are provided in Supporting Information, File S1.
Cell growth and stress treatment
YKO collection strains were pinned onto YEPD agar plates using a Singer ROTOR robot and grown for 2 d at 30°. The yeast were then pinned from the agar plates into 96-well plates containing 100 μl of YEPD per well and grown for 18–22 hr at 30°. The overnight cultures were then used to inoculate 2.2 ml deep-well plates (VWR), containing 550 μl of YEPD, and one sterile 3.2-mm stainless steel mixing bead per well, to an OD600 of 0.05, and loaded into the Liconic Incubator (shaking at 1200 rpm and 30°). Once the median OD600 of a plate reached 0.60 (no wells reached an OD600 of > 0.8), 150 μl of each culture was transferred to a 2.2 ml 96-well plate containing 850 μl of RNAse Inactivation Buffer per well (RI Buffer; 4 M ammonium sulfate, 100 mM MES buffer, and 20 mM EDTA, pH 4.6), and mixed thoroughly by pipetting; 100 μl of 1.875 M KCl, or 1 μg/ml rapamycin in 30° YEPD was then added to each remaining culture (yielding final concentration of 0.375 M KCl or 200 ng/ml rapamycin), and the plate was returned to the incubator for 19 min (shaking at 1200 rpm and 30°). The plate was then moved back to the deck of the robot, and 150 μl of culture removed from each well and added to RI Buffer as described above. The plates containing RI Buffer and yeast were then stored at –20°.
RNA purification
Plates containing cells in RI Buffer were defrosted by centrifugation (25 min at 3000 rpm at room temperature), and the supernatant removed from each well. The pelleted cells were then resuspended in 400 μl lysis buffer (4 M guanidine thiocyanate, 25 mM Na citrate, 0.5% N-lauryl sarcosine), and transferred to a 700 μl 96-well plate (Griener) containing 300 μl of zirconia/silica beads per well. The plates were then sealed with sterile foil and shaken for 5 min on a mini-Beadbeater-96 (Biospec). After a second round of centrifugation (25 min at 3000 rpm at 4°), the plates were loaded into the Biomek, where 100 μl of lysate was transferred to a sterile 96-well PCR plate (Thermo Scientific). At this point, 70 μl of isopropanol was added to each lysate and mixed for 1 min before adding 20 μl of MagMax binding beads (50% slurry in binding buffer; Ambion) to each well. The isopropanol, lysate, and bead mix was then mixed for 7 min to ensure all of the RNA in the sample bound to the beads, the plate was moved to a magnetic stand-96 (Ambion) for 5 min, and the liquid removed from each well. The beads were then washed with 150 μl of Wash Buffer 1 (1.7 M guanidine thiocyanate, 0.17% N-lauryl sarcosine, 33% isopropanol, 33 mM Na citrate, pH 7.0) for 5 min, followed by 150 μl of Wash Buffer 2 (2 M KCl, 80% ethanol, 2 mM Tris, pH 7.0) for 5 min. The DNA in each sample was then cleaved by treatment with Turbo DNAse (0.25 μl of 2 U/µl stock in 50 μl DNAse buffer from Life Technologies) for 25 min at room temperature. The RNA was then bound to the magnetic beads again by adding 100 μl of 1.5x Wash Buffer 1, and incubating for 5 min, the beads washed two more times with Wash Buffer 2 (5 min each), and dried for 10 min at room temperature. Finally, the purified RNA was eluted by mixing the beads with 30 μl of 55° elution buffer (1 mM sterile-filtered RNAse-free Tris pH 8.0) for 5 min, the plate was then returned to magnetic stand (to remove the beads), and the eluate transferred to a sterile PCR plate and stored at –80°.
qPCR
One-step qRT-PCR reactions were performed using 5 μl RNA, TaqMan probes/primers from Lifetech (used at the recommended concentrations; probe and primer sequences not provided by company), and 5 μl PerfeCTa qPCR ToughMix, Low ROX (Quanta) in a 96-well PCR plate using an Agilent Stratagene Mx3005p cycler. One TaqMan probe bound to the reporter gene NSR1 (labeled with FAM dye), and the other bound to a control gene, PEX6 or NTF2 (labeled with JOE dye). The ROX normalized data from each plate was then analyzed using the Stratagene MxPro software and fluorescence thresholds (dRn) of 0.120 for FAM (NSR1) and 0.60 for JOE (PEX6). Samples that passed the FAM or JOE threshold after >28 cycles were discarded. This filtering caused us to drop data from about 200 strains in the YKO library; most of these strains grew very poorly in the 96-well plates, leading to a low RNA yield.
qPCR normalization
To calculate the normalized NSR1/PEX6 and NSR1/NTF2 ratios, the FAM minus JOE (F–J) value was calculated for every well. The machine learning module, scikit-learn, in Python was then used to calculate the average F–J value for two populations on each plate—strains with expression defects, and strains without expression defects. This was done using Gaussian Mixture Models in the ‘scikit.mixture’ package with a covariance class of type ‘full’ for two-component analysis (http://scikit-learn.org/stable/modules/mixture.html#selecting-the-number-of-components-in-a-classical-gmm). The average F–J value for the strains without an expression defect was then subtracted from the F–J value of the entire plate, setting the mean of the plate (minus the outliers) to 0.0. All values were then multiplied by –1 so that higher RNA concentrations give higher NSR1/PEX6 ratios. This normalization had little impact on the list of strains that we identified as outliers in the screen but adjusts for the 0.3–0.6 cycle variation in the average NSR1/PEX6 ratio that we observe in separate runs on the qPCR machine.
Application of the method to other organisms and problems
The automated pipeline described here can (in theory) be used to study a wide variety of organisms/cell types. In most cases, this will require knocking down protein targets using siRNA or CRISPRi prior to stress treatment. The lysis step will also have to be optimized for each cell type. However, for organisms that do not have a cell wall it should be possible to perform chemical lysis on the deck of the robot and proceed directly to the RNA purification step. Finally, the primer sets used in the qPCR step will have to be optimized for each pathway and organism. The method described here could also be used to study RNA decay if a transcription inhibitor is added to the cells just prior to stress treatment.
Network reconstruction
Interactions between the top 440 genes/proteins in our screen were mapped using the protein–protein interaction data from BioGRID (version 3.4.125). TORC1 (Tor1, Kog1, Lst8, Tco89) was also added to our model as one merged node for reference. 275 proteins, including TORC1, form the major network, while 160 genes have no connection to any other of the 440 proteins identified in the screen. Note that the HSP70 family chaperones Ssa1 and Ssb1, and the RNA binding protein Slf1 were removed from the set (along with any proteins that only interact with them) in Figure 6 to eliminate nonspecific interactions (leaving 236 genes).
The interactions within the osmotic stress response network were mapped and clustered using Cytoscape (version 3.2.1). In Figure 6, node centers are colored based on the rapamycin data, with red nodes indicating a normalized F–J score of log2 ≥ 1, and gray nodes indicating log2 < 1, or no data. Node borders are colored based on selected GO Slim data (SGD GO Slim Mapper), where maroon indicates nuclear localization, and blue indicates endomembrane or vacuolar localization. Edges are colored based on the type of protein–protein data; Affinity Capture-Luminescence, Affinity Capture-MS, Affinity Capture-RNA, Affinity Capture-Western, and Reconstituted Complex are black; Two-hybrid and Protein-Fragment Complementation Assay are orange; finally, Biochemical Activity, Cocrystal Structure, Cofractionation, Colocalization, Copurification, and FRET are dotted gray.
DNA microarrays of Rpd3L mutants
Rpd3L and Rpd3S mutants were constructed using standard methods in an EYO690 (W303) background, as described in detail previously (Worley et al. 2013). Overnight cultures of the EY0690 or Rpd3L mutant strains were then used to inoculate 0.75 liter of YEPD to an OD600 of 0.1 in a 2.8-liter conical flask, and grown shaking at 200 rpm and 30°. Once the cultures reached an OD600 of 0.6, 250 ml of cells were collected by vacuum filtration and frozen in liquid nitrogen. The remaining cells were then subjected to 0.375 M KCl stress for 20 min, harvested by vacuum filtration, and frozen in liquid nitrogen. Finally, the mRNA was purified from the frozen cells, converted into cDNA using reverse transcription, labeled with Cy3 or Cy5, and examined using an Agilent microarray, as described previously (Capaldi 2010; Worley et al. 2013).
Results
Automated analysis of gene expression in yeast
We developed an automated pipeline and used it to measure the expression of a ribosome biogenesis gene (NSR1) in 4709 a-type strains from the yeast knock-out (YKO) collection (Winzeler et al. 1999; Giaever et al. 2002). This pipeline included three major steps (Figure 1A):
First, strains were grown to an OD600 of 0.6 in 96-well plates and exposed to 0.4 M KCl, 200 nM rapamycin, or mock stress. Then, at the peak of the stress response (20 min), 4 M ammonium sulfate (pH 4.6) was added to the cultures to promote protein precipitation, and block any further RNA synthesis or degradation.
Next, the 96-well plates were centrifuged to pellet the cells, and the ammonium sulfate solution was replaced with lysis buffer and glass beads. The cells were then lysed by bead-beating, and the plates centrifuged a second time to remove insoluble debris.
Finally, the RNA was purified from the lysates in each plate using silicon-coated magnetic beads, and loaded into a 96-well PCR plate. The gene expression levels in each strain were then measured using quantitative PCR—generally following expression of NSR1, and the housekeeping gene PEX6 (Figure 1, B and C).
All of the steps in the pipeline, with the exception of bead-beating and centrifugation, were performed on a Biomek FX liquid handling workstation with an integrated Liconic incubator. This ensured that all wells and plates were treated in an identical way, making it possible to compare data across strains and days (see Materials and Methods).
Testing the pipeline
To test our pipeline, we grew a 96-well plate with wild-type yeast in every well, and measured NSR1 and PEX6 expression. The NSR1 and PEX6 mRNA levels were consistent across the plate, with a log2 standard deviation of 0.86 and 0.90, respectively (<twofold average variation). Moreover, when we normalized the NSR1 data using the PEX6 data—to account for well-to-well variation in total RNA levels—we found that the standard deviation from the mean was only 0.37 on a log2 scale (∼30% average variation; Figure S1).
We then grew another plate of wild-type yeast, but this time treated half of the plate with mock stress (YEPD alone, every-other column) and the other half of the plate with 0.4 M KCl. The experiment showed that osmotic stress triggers a log2 = 2.3-fold average decrease in NSR1 expression (Figure 2). While this expression change is compressed compared to the log2 = 5-fold decrease we observe using microarray methods, the standard deviation from the mean in stress was only 0.26 on a log2 scale (0.36 for mock stress samples). Thus, the expression change in osmotic stress is approximately 10 times greater than the noise in our assay, indicating that our screen should be accurate enough to identify strains with moderate changes in NSR1 expression.
Analysis of the yeast knock-out collection
After we built and tested the automated pipeline, we used it to measure the osmotic stress response in strains from the YKO library (see Methods); collecting two sets of data for 6 of the 96-well plates in the library and one set of data for the other 48 plates in the library. We then normalized the NSR1/PEX6 values to set the average expression level of the library, excluding outlier strains, to log2 =0.0 (see Materials and Methods).
Inspecting the data from the screen revealed that most of the strains in the YKO collection have a similar NSR1/PEX6 ratio, with log2 values ranging from –1.0 to +1.0 (Figure 3A). However, there were also over 400 outlier strains, with NSR1/PEX6 ratios ranging from log2 = 1.5 to 4.5 (Figure 3A).
To estimate the significance of these results, we analyzed the data from the six plates (560 strains), which were run through the pipeline twice (on separate days; Figure 3B). Overall, we found a good correlation between replicates, with a Pearson’s r of 0.90, and an average difference between measurements of log2 = 0.29. Taking this latter value as a good estimate of the average error, we then modeled the log data for the complete screen using a normal distribution with a mean of 0.0 and a standard deviation of 0.3 (Figure 3A). This model fit the data for strains with NSR1/PEX6 ratios between –1.0 and ∼0.5 very well, indicating that the variation in this range is simply due to the error in our assay. By corollary, we could then estimate the probability that a strain has a log2 NSR1/PEX6 ratio larger than 1.0 by chance at less than 0.1% (3.3 Z-score; Figure 3A).
Our statistical analysis suggested that there are 734 strains with a significant defect in stress dependent repression of NSR1 (log2 > 1.0; P < 0.001). However, there were two potential problems with this interpretation of the data. First, our error model is based on data from six out of 54 plates in the library, and, thus, if the error varied from plate to plate, we could be overestimating the number of strains with real defects in NSR1 repression. Second, our analysis assumes that the expression level of the housekeeping gene PEX6 is constant across all YKO collection strains, but some strains may have a higher NSR1/PEX6 ratio than expected due to a decrease in PEX6 expression.
To address these issues, we took all of the strains with a normalized NSR1/PEX6 ratio log2 > 1.3 (rearrayed onto six plates containing 494 strains plus 72 center peak [log2 = 0] controls for normalization) and ran them through our pipeline again. However, this time we measured the stress-dependent changes in the expression level of NSR1, and a different housekeeping gene: NTF2. Just over 85% of the 494 strains had log2 > 1.0-fold more NSR1/NTF2 than the control strains, leaving 440 strains that have significantly more NSR1 expression (P < 0.001) than the average strain in the YKO library in two separate assays (Table S1).
Identification of known components in the cell growth control circuit
To estimate the false negative rate in our screen, we examined the screen data for strains missing known components in the Ribi gene control circuit. As described in the Introduction, TORC1, Sch9, Kcs1, Vip1, Hog1, and Rpd3L are all known to play a role in downregulating Ribi gene expression during osmotic stress. However, strains missing the TORC1 components Tor1, Kog1, Lst8 and Tco89, and the kinase Sch9 should not (and do not) show up as hits in our screen since Tor1 acts redundantly with Tor2; Tco89 has a very limited impact on TORC1 signaling; and Kog1, Lst8 and Sch9 are essential genes and thus not in the YKO library (Winzeler et al. 1999; Giaever et al. 2002; Loewith et al. 2002).
We did find a log2 = 3.1, 1.1, and 0.6 increase in NSR1 expression in the kcs1Δ, vip1Δ and hog1Δ strains from the YKO collection. These numbers align reasonably well with those from our previous work, where we found that deletion of Kcs1, Vip1 and Hog1 in the W303 background all caused an approximately twofold increase in Ribi gene expression in osmotic stress (Worley et al. 2013; Hughes Hallett et al. 2014). The one outlier was the kcs1Δ strain from the YKO library (which has a larger increase in NSR1 expression than expected), but previous work has shown that this strain behaves abnormally, and is likely carrying multiple mutations (Huang and O’Shea 2005).
We also found expression changes in YKO collection strains missing some, but not all, of the Rpd3L subunits. Previous studies have shown that Rpd3 and Pho23 are required for Ribi gene repression in stress, but little is known about the role that the other subunits in Rpd3L play in stress conditions (Alejandro-Osorio et al. 2009). Therefore, to build a more complete picture of Rpd3L function—and calibrate our screen—we made 14 strains, each missing one subunit of Rpd3L (Rpd3, Sin3, Ume1, Pho23, Sap30, Sds3, Cti6, Rxt2, Rxt3, Dep1, Ume6 and Ash1), or, as a control Rpd3S (Eaf3, Rco1), and measured their response to 0.4 M KCl using DNA microarrays (Carrozza et al. 2005a, 2005b).
Our microarray analysis revealed that the 14 strains missing Rpd3L or Rpd3S subunits fall into three groups (Figure 4A). The first group of strains (rpd3Δ, sin3Δ, pho23Δ, dep1Δ, sds3Δ, sap30Δ, and rxt2Δ) has a large defect in Ribi and RP gene repression; the second group (ume1Δ, cti6Δ, rxt3Δ, ash1Δ) has a weak to moderate defect in Ribi and RP gene repression; while the third group (ume6Δ, rco1Δ, eaf3Δ) has no defect in Ribi or RP gene repression.
Comparing the microarray and screen data revealed a clear trend; the screen picked up strains with large defects in NSR1 repression but not strains with small to moderate defects in NSR1 repression (Figure 4B). In fact, six out of seven gene deletions that caused a strong defect in NSR1 downregulation were identified as hits (log2 > 1.0) in the screen (Figure 4B). The only exception was sds3Δ, but in further testing we found that the inconsistency was caused by additional mutations in the strain from the YKO collection (Figure S2). In contrast, zero out of four gene deletions that caused a small to moderate defect in NSR1 downregulation in the microarray experiments were identified as hits (Figure 4B). It is therefore likely that the 440 strains with log2 > 1.0 more NSR1 expression during stress than the control strains includes most, if not all, of the strains in the YKO library with a strong defect in Ribi gene (NSR1) repression, but few strains with small-to-moderate defects in Ribi gene repression.
Complexity of yeast stress and cell growth control network
To begin to make sense of the screen data, we set out to organize the strains with high NSR1 expression into groups. As a first step, we ran the 332 strains with NSR1 expression log2 > 1.4 in KCl (four plates with center peak controls for normalization; the maximum that can be processed in parallel) through our pipeline, treating them with mock stress. This experiment revealed that most of the strains with high levels of NSR1 expression in stress (top panel, Figure 5) have normal, or near normal, NSR1 expression levels during log phase growth (middle panel, Figure 5). In fact, the average NSR1/PEX6 ratio of the 332 strains in mock stress was log2 = 0.33, just 26% above that of the center peak control strains. Moreover, there were only five strains with log2 > 1.0 more NSR1 expression than the controls: mch5Δ (log2 = 2.6), rpl16bΔ (log2 = 1.8) puf4Δ (log2 = 1.7), rpl7aΔ (log2 = 1.2), and rps7bΔ (log2 = 1.1).
We then ran the 332 strains through our pipeline again, but this time treated them with the potent TORC1 inhibitor rapamycin. This experiment showed that 53 out of the 332 strains only partially downregulate NSR1 in rapamycin (normalized NSR1/PEX6 of log2 > 1.0), and are therefore missing genes that act downstream of TORC1 (bottom panel of Figure 5, and Table S1). Many of these 53 genes are involved in gene regulation, including 30 genes that regulate transcription [P < 0.001 by gene ontology (GO) analysis], and 16 genes involved in chromatin organization and biogenesis (P = 2e–4). In contrast, the 279 genes that act upstream of TORC1, or in parallel with the TORC1 pathway (log2 < 1.0 normalized NSR1 expression), tend to be involved in vacuolar function (30 genes, P = 4e–7) or cation homeostasis (15 genes, P = 5e–4), but not transcription (P = 3e–4 underrepresentation).
Next, to organize the hits from our screen into functional modules, we constructed a model of the Ribi gene control circuit using the physical interaction data from BioGRID (Stark et al. 2006). Overall, we found 1076 connections between the 440 genes/proteins with log2 > 1.0 NSR1 expression in salt (not including self–self interactions; see Materials and Methods). To test if this number of connections is significant, we also constructed 10,000 random networks, each containing 440 out of the 4709 genes studied in the screen. These networks all had less than 980 interactions (492 interactions on average), suggesting that the probability of finding 1076 connections by chance is less than 0.01%.
Clustering the physical interaction data using Cytoscape (Shannon et al. 2003) revealed a network made up of two parts (Figure 6). The upper half includes 118 proteins connected primarily via weak or transient interactions (orange lines representing yeast two-hybrid and other weak interactions, but not IP data; Figure 6). These proteins are localized primarily to the vacuole and endomembrane system (56 blue encircled nodes; Figure 6 and Table 1) and form three distinct groups. The first group includes the A, B, C, and D subunits of the V1 portion of the vacuolar ATPase (Vma1, Vma2, Vma5, and Vma8), the c, c’, c”, and d subunits of the Vo portion of the vacuolar ATPase (Vma3, Vma11, Vma16, and Vma6), and three associated proteins (Vma21, Vma22, and Pkr1). The second group includes two components of the EGO complex [a known regulator of autophagy and TORC1 (Binda et al. 2009); Slm4 and Meh1], two components of the vacuolar transporter chaperone (VTC) complex, and the transporter Gap1 (EGO and VTC; Figure 6). The third group includes endosomal and vacuolar SNARE proteins (Syn8, Vam3 and Vam7), the vacuolar Rab family GTPase, Ypt7 [involved in vacuole and endosome fusion; (Schimmoller and Riezman 1993)], and a component of the CORVET membrane-tethering complex on the vacuole, Pep5. Twenty-two other genes, distributed throughout the upper portion of the network, are also involved in vesicle trafficking (bottom, Table 1), including numerous steps in transporting cargo from the ER through the Golgi and to the vacuole (Gyp5, Yip5, Emp70, Vfa1, Vab2 and Rcr1), and from the cytoplasm to vacuole (Snx4, Pfa3 and Vac8).
Table 1. Vacuolar, endomembrane, and vesicle trafficking genes required for the downregulation of the Ribi gene NSR1 in stress.
Name | Description | Loc | [NSR1] | Down TOR | Phys Net |
---|---|---|---|---|---|
VMA1 | Subunit A of the V1 peripheral membrane domain of V-ATPase | V | 2.2 | No | Yes |
VMA2 | Subunit B of V1 peripheral membrane domain of vacuolar H+-ATPase | V | 2.3 | Yes | Yes |
VMA3 | Proteolipid subunit c of the V0 domain of vacuolar H(+)-ATPase | V | 1.9 | No | Yes |
VMA5 | Subunit C of the V1 peripheral membrane domain of V-ATPase | V | 2.2 | No | Yes |
VMA6 | Subunit d of the V0 integral membrane domain of V-ATPase | V | 2.1 | No | Yes |
VMA8 | Subunit D of the V1 peripheral membrane domain of V-ATPase | V | 2.1 | No | Yes |
VMA11 | Vacuolar ATPase V0 domain subunit c’ | V | 1.5 | No | Yes |
VMA16 | Subunit c’’ of the vacuolar ATPase | V | 1.9 | No | Yes |
VMA21 | Integral membrane protein required for V-ATPase function | ER | 1.5 | No | Yes |
VMA22 | Protein that is required for vacuolar H+-ATPase (V-ATPase) function | ER | 1.9 | No | Yes |
PKR1 | V-ATPase assembly factor | ER | 1.9 | No | Yes |
SLM4 | Component of the EGO and GSE complexes | V | 3.7 | No | Yes |
MEH1 | Component of the EGO and GSE complexes | V | 1.5 | No | Yes |
VTC1 | Subunit of the vacuolar transporter chaperone (VTC) complex | ER/V | 1.4 | No | Yes |
VTC4 | Vacuolar membrane polyphosphate polymerase | ER/V | 2.3 | No | Yes |
GAP1 | General amino acid permease | V | 1.9 | No | Yes |
SYN8 | Endosomal SNARE related to mammalian syntaxin 8 | Endo | 1.8 | No | Yes |
VAM3 | Syntaxin-like vacuolar t-SNARE | V | 2.6 | No | Yes |
VAM7 | Vacuolar SNARE protein | V | 2.4 | No | Yes |
YPT7 | Rab family GTPase | V | 2.5 | Yes | Yes |
PEP5 | Histone E3 ligase, component of CORVET membrane tethering complex | V | 1.9 | No | Yes |
RCR1 | Involved in chitin deposition; may function in endosomal-vacuolar trafficking | ER | 2.0 | No | No |
YOP1 | Membrane protein that interacts with Yip1p to mediate membrane traffic | ER | 1.7 | No | Yes |
GYP5 | GTPase-activating protein (GAP) for yeast Rab family members | G | 1.8 | No | Yes |
RGP1 | Subunit of a Golgi membrane exchange factor (Ric1p-Rgp1p) | G | 1.4 | No | No |
SYS1 | Integral membrane protein of the Golgi | G | 1.8 | No | Yes |
TVP15 | Integral membrane protein; localized to late Golgi vesicles | G | 1.8 | No | Yes |
TVP38 | Integral membrane protein; localized to late Golgi vesicles | G | 1.9 | No | Yes |
VPS52 | Component of the GARP (Golgi-associated retrograde protein) complex | G | 1.3 | No | No |
YIP5 | Protein that interacts with Rab GTPases; localized to late Golgi vesicles | G | 1.6 | No | Yes |
EMP70 | Endosome-to-vacuole sorting | V | 1.6 | No | Yes |
SNX4 | Sorting nexin; involved in the retrieval of late-Golgi SNAREs | Endo | 2.0 | No | Yes |
SNX41 | Sorting nexin; involved in the retrieval of late-Golgi SNAREs | Endo | 2.0 | No | Yes |
VFA1 | Protein that interacts with Vps4p and has a role in vacuolar sorting | Endo | 1.8 | No | Yes |
VPS5 | Nexin-1 homolog; moves proteins from endosomal compartment to Golgi | Endo | 1.7 | No | Yes |
PFA3 | Palmitoyltransferase for Vac8p | V | 2.4 | No | Yes |
VAC8 | Phosphorylated and palmitoylated vacuolar membrane protein | V | 2.9 | No | Yes |
LST4 | Protein possibly involved in a post-Golgi secretory pathway | 2.7 | Yes | No | |
EDE1 | Scaffold protein involved in the formation of early endocytic sites | 1.6 | No | Yes | |
ENT2 | Epsin-like protein required for endocytosis and actin patch assembly | 1.8 | No | Yes | |
KIN2 | Serine/threonine protein kinase involved in regulation of exocytosis | 1.7 | ? | YES | |
VAB2 | Subunit of the BLOC-1 complex involved in endosomal maturation | 2.4 | ? | YES | |
MDR1 | Cytoplasmic GTPase-activating protein; regulation of Golgi secretory function | 2.4 | No | No | |
APL4 | Gamma-adaptin | Endo | 1.8 | No | Yes |
APM1 | Mu1-like medium subunit of the AP-1 complex | G | 1.8 | No | Yes |
CHC1 | Clathrin heavy chain | 1.5 | ? | YES | |
DYN1 | Cytoplasmic heavy chain dynein | 1.7 | ? | YES |
The top three groups of genes encode proteins highlighted in the top portion of the physical interaction (Phys Net) network shown in Figure 6; V-ATPase, EGO/VTC, and CORVET/SNARE, respectively. The fourth group lists other genes found in our screen encoding vacuolar, vesicle transport of endomembrane proteins. The third column lists the localization (Loc) of each protein. The fourth column [NSR1] lists the log2 NSR1/PEX6 expression ratio from the screen. The fifth column notes if the gene acts downstream of TORC1 (has log2 > 1 normalized NSR1/PEX6 ratio in rapamycin). The sixth column states whether the genes is part of the physical interaction network shown in Figure 6. V, vacuole; ER, endoplasmic reticulum; G, Golgi; Endo, other parts of the Endomembrane system. A question mark means that the protein/gene was not analyzed in the rapamycin subscreen.
Interestingly, almost all of the proteins in the upper portion of the Ribi gene control network, act upstream of TORC1, or in parallel with the TORC1 pathway (gray nodes in Figure 6 and Table 1). Consistent with this, TORC1 itself (green node; Figure 6) interacts with several proteins in this portion of the network (Table 2), including Vac8, a part of the CVT pathway, and Gyp5 (a GTPase-activating protein involved in ER-to-Golgi transport), and the kinases Nnk1, Fmp48 and Kdx1—forming a total of 17 interactions with proteins in the upper and lower parts of the network (Table 2).
Table 2. Proteins required for the downregulation of the Ribi gene NSR1 in stress that physically interact with TORC1.
Name | Description | Loc | [NSR1] | Down TOR |
---|---|---|---|---|
VAC8 | Vacuolar membrane protein; CVT pathway | C | 2.9 | Yes |
GYP5 | GTPase-activating protein for Rab proteins; ER to Golgi transport | C | 1.8 | No |
DAL82 | Positive regulator of allophanate inducible genes | N | 2.6 | No |
FMP48 | Protein kinase | C/M | 1.7 | No |
KDX1 | Protein kinase | M | 1.5 | No |
NNK1 | Protein kinase | C | 1.8 | No |
SAP185 | Protein that forms a complex with the Sit4p protein phosphatase | C/M | 1.9 | Yes |
POP2 | RNase of the DEDD superfamily | C | 1.4 | Yes |
TIF1 | Translation initiation factor eIF4A | C | 1.6 | ? |
MRPS17 | Mitochondrial ribosomal protein of the small subunit | C | 1.5 | ? |
GAS1 | Beta-1,3-glucanosyltransferase | C/M/N | 1.1 | ? |
HXT2 | High-affinity glucose transporter of the major facilitator superfamily | 1.9 | ? | |
ICL1 | Isocitrate lyase | C | 2.1 | No |
SAC6 | Fimbrin, actin-bundling protein | C | 1.8 | No |
TPO3 | Polyamine transporter of the major facilitator superfamily | C | 1.7 | ? |
YKU80 | Subunit of the telomeric Ku complex (Yku70p-Yku80p) | N | 1.5 | ? |
YLR108C | Protein of unknown function | N | 1.8 | Yes |
The third column lists the localization (Loc) of each protein. The fourth column [NSR1] lists the log2 NSR1/PEX6 expression ratio from the screen. The fifth column notes if the gene/protein acts downstream of TORC1 (has log2 > 1 normalized NSR1/PEX6 ratio in rapamycin). A question mark means that the protein/gene was not analyzed in the rapamycin subscreen. C, cytosol; N, nucleus; M, membrane.
In the lower half of the network (also 118 genes) we find two highly connected nodes, the histone H3 proteins, Hht1/Hht2 (merged into one node for simplicity, and shown in yellow in Figure 6). Hht1/Hht2 in turn form strong interactions with three major complexes (black lines showing IP data, Figure 6). The first includes the six core subunits of Rpd3L (Rpd3, Sin3, Pho23, Sap30, Dep1, and Rxt2), as well as another Class I HDAC Hos1, and the Sin3 associated transcription factor Stb4 (Table 3). The second includes three components of the Elongator complex (part of the Pol II holoenzyme responsible for transcriptional elongation; Elp3, Elp6 and Iki3), as well as an associated kinase, Vhs1 (Table 3). The third includes 13 ribosomal proteins and four ribosome-associated proteins (Table 3).
Table 3. Ribosomal and nuclear genes required for the down regulation of the Ribi gene NSR1 in stress.
Name | Description | Loc | [NSR1] | Down TOR | Phys Net |
---|---|---|---|---|---|
ELP3 | Subunit of Elongator complex | N | 2.8 | Yes | Yes |
ELP6 | Subunit of Elongator complex | 1.8 | Yes | Yes | |
IKI3 | Subunit of Elongator complex | N | 1.8 | Yes | Yes |
VHS1 | Cytoplasmic serine/threonine protein kinase | 2.5 | No | Yes | |
RPD3 | Histone deacetylase, component of Rpd3S and Rpd3L | N | 2.1 | No | Yes |
SIN3 | Component of Rpd3S and Rpd3L | N | 2.6 | Yes | Yes |
PHO23 | Component of Rpd3L | N | 2.4 | Yes | Yes |
SAP30 | Component of Rpd3L | N | 2.2 | Yes | Yes |
DEP1 | Component of the Rpd3L | N | 2.6 | Yes | Yes |
RXT2 | Component of Rpd3L | N | 2.4 | Yes | Yes |
HOS1 | Class I histone deacetylase | N | 1.9 | No | Yes |
STB4 | Putative transcription factor | N | 2.4 | No | Yes |
RPS6A | Protein component of the small (40S) ribosomal subunit | R | 2.4 | Yes | Yes |
RPS7B | Protein component of the small (40S) ribosomal subunit | R | 1.4 | Yes | Yes |
RPS9A | Protein component of the small (40S) ribosomal subunit | R | 1.9 | No | Yes |
RPS22A | Protein component of the small (40S) ribosomal subunit | R | 1.4 | No | Yes |
RPS17A | Protein component of the small (40S) ribosomal subunit | R | 2.4 | Yes | Yes |
RPL2B | Ribosomal 60S subunit protein L2B | R | 1.3 | No | Yes |
RPL6A | Ribosomal 60S subunit protein L6A | R | 2.1 | No | Yes |
RPL6B | Ribosomal 60S subunit protein L6B | R | 2.6 | Yes | Yes |
RPL7A | Ribosomal 60S subunit protein L7A | R | 2.1 | No | Yes |
RPL13A | Ribosomal 60S subunit protein L13A | R | 1.8 | No | Yes |
RPL16B | Ribosomal 60S subunit protein L16B | R | 1.8 | No | Yes |
RPL22A | Ribosomal 60S subunit protein L22A | R | 1.9 | No | Yes |
RPL24A | Ribosomal 60S subunit protein L24A | R | 2.0 | Yes | Yes |
SSZ1 | Hsp70 protein that interacts with Zuo1p (a DnaJ homolog) | 2.0 | Yes | Yes | |
ZUO1 | Ribosome-associated chaperone | R/N | 1.9 | Yes | Yes |
NOP12 | Nucleolar protein involved in pre25S rRNA processing | N | 2.1 | No | Yes |
RQC1 | Component of the ribosome quality control complex (RQC) | R | 2.0 | No | Yes |
RPL38 | Ribosomal 60S subunit protein L38 | R | 2.0 | Yes | No |
RPL43B | Ribosomal 60S subunit protein L43B | R | 1.6 | No | No |
RPS27A | Protein component of the small (40S) ribosomal subunit | R | 2.1 | No | No |
CLU1 | Subunit of the eukaryotic translation initiation factor 3 (eIF3) | 2.3 | Yes | Yes | |
EFT1 | Elongation factor 2 (EF-2), also encoded by EFT2 | R | 1.6 | No | Yes |
TIF1 | Translation initiation factor eIF4A | R | 1.6 | No | Yes |
YGR054W | Eukaryotic initiation factor (eIF) 2A | R | 2.2 | No | Yes |
CAF20 | Phosphoprotein of the mRNA cap-binding complex | 2.0 | No | Yes | |
ASK10 | Component of RNA polymerase II holoenzyme | N | 2.4 | No | Yes |
CAF130 | Subunit of the CCR4-NOT transcriptional regulatory complex | 1.6 | No | Yes | |
ELA1 | Elongin A; Required for Pol II degradation | N | 2.6 | No | Yes |
ELC1 | Elongin C; Required for Pol II degradation | N | 1.5 | No | Yes |
PGD1 | Subunit of the RNA polymerase II mediator complex | N | 2.0 | No | Yes |
NUT1 | Component of the RNA polymerase II mediator complex | N | 1.7 | No | Yes |
GIS1 | Histone demethylase and transcription factor | N | 1.7 | No | Yes |
HIR2 | Subunit of HIR nucleosome assembly complex | N | 2.0 | No | Yes |
HIR3 | Subunit of the HIR complex | N | 2.5 | No | Yes |
HPA2 | Tetrameric histone acetyltransferase | 1.9 | No | Yes | |
HTA1 | Histone H2A | N | 2.4 | Yes | Yes |
IES4 | Component of the INO80 chromatin remodeling complex | N | 1.8 | Yes | Yes |
ITC1 | Subunit of Isw2p-Itc1p chromatin remodeling complex | N | 1.6 | No | Yes |
DPB4 | Subunit of ISW2 chromatin accessibility complex | N | 2.0 | No | Yes |
JHD2 | JmjC domain family histone demethylase | N | 2.2 | Yes | Yes |
RLF2 | Largest subunit (p90) of the Chromatin Assembly Complex (CAF-1) | N | 2.5 | Yes | Yes |
SAS5 | Subunit of the SAS complex (Sas2p, Sas4p, Sas5p) | N | 2.2 | No | Yes |
SWI3 | Subunit of the SWI/SNF chromatin remodeling complex | N | 2.5 | Yes | Yes |
The top three groups of genes encode proteins highlighted in the bottom portion of the physical interaction network shown in Figure 6; Elongator, Rpd3L, and Ribosome, respectively. Note that three ribosomal proteins not connected to the others by physical interactions were included in the list. The fourth group lists other genes found in our screen involved in transcription and chromatin remodeling, all of which are part of the lower half of the physical interaction network in Figure 6. The third column lists the localization (Loc) of each protein: The fourth column [NSR1] lists the log2 NSR1/PEX6 expression ratio from the screen. The fifth column notes if the gene acts downstream of TORC1 (has log2 > 1 normalized NSR1/PEX6 ratio in rapamycin). The sixth column states whether the genes is part of the physical interaction network (Phys Net) shown in Figure 6. N, nuclear; R, ribosome.
Hht1/Hht2 also interact with numerous other nuclear proteins involved in NSR1 regulation (54 maroon encircled nodes, Figure 6), including histone 2a, components of the ISW2, INO80 and SWI/SNF chromatin remodeling complexes, as well as numerous factors involved in translation and RNA decay (bottom, Table 3). Interestingly, many of the proteins in the lower half of the network, particularly those involved in chromatin remodeling and transcription, act downstream of TORC1 as per our rapamycin data (34 red nodes, Figure 6).
Outside of the portion of the Ribi gene control network connected by known physical interactions, there are many important proteins/genes (Table S1). The only enriched group includes 21 genes involved in nitrogen metabolism (P = 9e–5). However, there are also 56 enzymes in the unconnected portion of the network (including five kinases; Adk1, Bud17, Dgk1, Lsb6, and Yfh7; and five methyltransferases; Mtq2, Sam4, Trm12, Trm44, and Ymr310c), along with nine transmembrane transporters (Dip5, Hxt14, Mep1, Mup3, Pdr10, Sit1, Tom7, Ydr387c, and Yfl040w), and eight DNA binding proteins (Dal82, Hal9, Hcm1, Hop1, Sip4, Sok2, Sut2 and Znf1). These proteins may interact with components in the cell growth control network during osmotic stress—a stimulus rarely applied during large-scale studies of protein interactions and thus missing from the physical interaction network—or alter network activity by affecting the level of key metabolites in the cell.
Discussion
We have identified 440 strains from the YKO collection that have a strong and reproducible defect in Ribi gene (NSR1) repression during osmotic stress. The proteins/genes knocked out in these strains fall into three major groups:
(1) The NSR1/Ribi regulation network contains 37 proteins involved in vesicle trafficking, 11 components of the vacuolar ATPase, and 50 other proteins that act as part of the endomembrane system (Table 1 and Table S1). These proteins probably influence NSR1 expression in a variety of ways.
Some of these proteins may directly, or indirectly, inhibit TORC1 signaling in stress. In line with this hypothesis, we found that strains missing components of the EGO complex (Meh1 and Slm4) and vacuolar ATPase–known regulators of TORC1 signaling in other conditions (Binda et al. 2009; Zoncu et al. 2011)–have large defects in NSR1 downregulation.
Other vacuole or endomembrane proteins may be important for the transport of proteins that interact with, or support the function of, TORC1 and EGO on the vacuolar membrane.
Yet other proteins in this group may be required for nutrient transport and storage, and thus deleting them could lead to changes in TORC1 and cell growth signaling. In fact, Cardenas and coworkers have already shown that disruption of the CORVET and HOPS complexes–complexes also identified in our study–cause partial inactivation of TORC1 signaling during log phase growth by inhibiting the activation of the EGO complex members Gtr1/Gtr2 (Zurita-Martinez et al. 2007). This constitutive TORC1 repression may then desensitize the TORC1 pathway to inhibition by osmotic stress (Figure S3).
(2) The NSR1 regulation network contains at least 24 proteins involved in chromatin silencing, six proteins involved in general transcription, and nine other DNA binding proteins (Table 3). Six of these proteins are subunits of the Class I HDAC Rpd3L—a complex that deacetylates the nucleosomes in Ribi gene promoters whenever TORC1 is inactivated (Humphrey et al. 2004; Huber et al. 2011). However, the other proteins identified in this group have not been linked to Ribi gene regulation previously. Some of these proteins probably cooperate with Rpd3L to inactivate NSR1 in stress—this is almost certainly the case for the histone H3 and H2A proteins—but others may simply regulate the transcription of critical proteins in the stress response network.
(3) The NSR1 regulation network also contains 17 ribosomal and ribosome-associated proteins, and four translation factors (Table 3). Although it is unclear how these proteins interact with the Ribi gene control network, it is well established that blocking translation using the drug cycloheximide triggers hyperactivation of TORC1 (Hara et al. 1998; Beugnet et al. 2003; Urban et al. 2007). It therefore seems likely that deletion of at least some of the proteins found in this group will have a similar indirect effect on TORC1 activity by inhibiting translation.
On top of the three major groups listed above, we also found three proteins known to play a role in PKA signaling (Ira2, Gpb1, and Gpr1) in our core 440 gene network, and two others (Pde1 and Pde2) that just missed the log2 > 1.0 cutoff (Table S1). Four of these proteins (Ira2, Gpb1, Pde1, and Pde2) are involved in limiting PKA pathway activity (Broach 2012)—suggesting that hyperactivation of the PKA pathway helps compensate for TORC1 inactivation in osmotic stress. Proteins that indirectly limit PKA pathway activity may also be part of the NSR1 regulation network.
Putting the groups of proteins listed above together with the myriad other proteins required for NSR1 repression in stress (listed in Table S1) it is clear that the Ribi, and thus the cell growth control, network is highly complex. Over seven percent of the genome (440/5820 genes) is required for proper signaling in osmotic stress conditions alone. Therefore, numerous follow up experiments will be needed to determine how such a large array of proteins contributes to the osmotic stress response. In this respect, we hope that our screen will serve as a resource that helps guide others toward key proteins and pathways in cell growth control, but remind the reader that some of our data may be misleading as many strains in the YKO collection carry mutations beyond the annotated deletion (Hughes et al. 2000; Teng et al. 2013; Giaever and Nislow 2014).
The data presented in this paper also demonstrate the power of our new method for mapping gene regulatory circuits in yeast (and potentially other organisms). It is highly quantitative, reproducible, and works well even when the resulting gene expression changes are short lived, or involve a dramatic reduction in mRNA levels. Furthermore, the method can (at least in principle) be adapted to map the regulators of any gene, simply by altering the primers/probes used in the qPCR step.
Supplementary Material
Acknowledgments
We would like to thank Christopher Martinez and Gabrielle Martinez for help programming and running the Biomek robot and Steven Fan for setting up the microarray database. This work was supported by the National Institutes of Health grants 1R01GM097329 and 5T32GM008659.
Footnotes
Supporting information is available online at www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.025882/-/DC1
Communicating editor: B. J. Andrews
Literature Cited
- Alejandro-Osorio A. L., Huebert D. J., Porcaro D. T., Sonntag M. E., Nillasithanukroh S., et al. , 2009. The histone deacetylase Rpd3p is required for transient changes in genomic expression in response to stress. Genome Biol. 10: R57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barbet N. C., Schneider U., Helliwell S. B., Stansfield I., Tuite M. F., et al. , 1996. TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 7: 25–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beugnet A., Wang X., Proud C. G., 2003. Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1. J. Biol. Chem. 278: 40717–40722. [DOI] [PubMed] [Google Scholar]
- Binda M., Peli-Gulli M. P., Bonfils G., Panchaud N., Urban J., et al. , 2009. The Vam6 GEF controls TORC1 by activating the EGO complex. Mol. Cell 35: 563–573. [DOI] [PubMed] [Google Scholar]
- Brandman O., Stewart-Ornstein J., Wong D., Larson A., Williams C. C., et al. , 2012. A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 151: 1042–1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brauer M. J., Huttenhower C., Airoldi E. M., Rosenstein R., Matese J. C., et al. , 2008. Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeast. Mol. Biol. Cell 19: 352–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Broach J. R., 2012. Nutritional control of growth and development in yeast. Genetics 192: 73–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Capaldi A. P., 2010. Analysis of gene function using DNA microarrays. Methods Enzymol. 470: 3–17. [DOI] [PubMed] [Google Scholar]
- Cardenas M. E., Cutler N. S., Lorenz M. C., Di Como C. J., Heitman J., 1999. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev. 13: 3271–3279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carrozza M. J., Florens L., Swanson S. K., Shia W. J., Anderson S., et al. , 2005a Stable incorporation of sequence specific repressors Ash1 and Ume6 into the Rpd3L complex. Biochim. Biophys. Acta 1731: 77–87, discussion 75–76. [DOI] [PubMed] [Google Scholar]
- Carrozza M. J., Li B., Florens L., Suganuma T., Swanson S. K., et al. , 2005b Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123: 581–592. [DOI] [PubMed] [Google Scholar]
- Duvel K., Santhanam A., Garrett S., Schneper L., Broach J. R., 2003. Multiple roles of Tap42 in mediating rapamycin-induced transcriptional changes in yeast. Mol. Cell 11: 1467–1478. [DOI] [PubMed] [Google Scholar]
- Gasch A. P., Spellman P. T., Kao C. M., Carmel-Harel O., Eisen M. B., et al. , 2000. Genomic expression programs in the response of yeast cells to environmental changes. Mol. Biol. Cell 11: 4241–4257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giaever G., Nislow C., 2014. The yeast deletion collection: a decade of functional genomics. Genetics 197: 451–465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giaever G., Chu A. M., Ni L., Connelly C., Riles L., et al. , 2002. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418: 387–391. [DOI] [PubMed] [Google Scholar]
- Hara K., Yonezawa K., Weng Q. P., Kozlowski M. T., Belham C., et al. , 1998. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273: 14484–14494. [DOI] [PubMed] [Google Scholar]
- Heitman J., Movva N. R., Hall M. N., 1991. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253: 905–909. [DOI] [PubMed] [Google Scholar]
- Hsu P. P., Kang S. A., Rameseder J., Zhang Y., Ottina K. A., et al. , 2011. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332: 1317–1322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang S., O’Shea E. K., 2005. A systematic high-throughput screen of a yeast deletion collection for mutants defective in PHO5 regulation. Genetics 169: 1859–1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huber A., Bodenmiller B., Uotila A., Stahl M., Wanka S., et al. , 2009. Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev. 23: 1929–1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huber A., French S. L., Tekotte H., Yerlikaya S., Stahl M., et al. , 2011. Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L. EMBO J. 30: 3052–3064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes Hallett J. E., Luo X., Capaldi A. P., 2014. State transitions in the TORC1 signaling pathway and information processing in Saccharomyces cerevisiae. Genetics 198: 773–786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes T. R., Roberts C. J., Dai H., Jones A. R., Meyer M. R., et al. , 2000. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat. Genet. 25: 333–337. [DOI] [PubMed] [Google Scholar]
- Humphrey E. L., Shamji A. F., Bernstein B. E., Schreiber S. L., 2004. Rpd3p relocation mediates a transcriptional response to rapamycin in yeast. Chem. Biol. 11: 295–299. [DOI] [PubMed] [Google Scholar]
- Jonikas M. C., Collins S. R., Denic V., Oh E., Quan E. M., et al. , 2009. Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum. Science 323: 1693–1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jorgensen P., Rupes I., Sharom J. R., Schneper L., Broach J. R., et al. , 2004. A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 18: 2491–2505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim D. H., Sarbassov D. D., Ali S. M., King J. E., Latek R. R., et al. , 2002. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163–175. [DOI] [PubMed] [Google Scholar]
- Kim E., Goraksha-Hicks P., Li L., Neufeld T. P., Guan K. L., 2008. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10: 935–945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laplante M., Sabatini D. M., 2012. mTOR signaling in growth control and disease. Cell 149: 274–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee J., Moir R. D., Willis I. M., 2009. Regulation of RNA polymerase III transcription involves SCH9-dependent and SCH9-independent branches of the target of rapamycin (TOR) pathway. J. Biol. Chem. 284: 12604–12608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee M. V., Topper S. E., Hubler S. L., Hose J., Wenger C. D., et al. , 2011. A dynamic model of proteome changes reveals new roles for transcript alteration in yeast. Mol. Syst. Biol. 7: 514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lempiainen H., Uotila A., Urban J., Dohnal I., Ammerer G., et al. , 2009. Sfp1 interaction with TORC1 and Mrs6 reveals feedback regulation on TOR signaling. Mol. Cell 33: 704–716. [DOI] [PubMed] [Google Scholar]
- Liko D., Slattery M. G., Heideman W., 2007. Stb3 binds to ribosomal RNA processing element motifs that control transcriptional responses to growth in Saccharomyces cerevisiae. J. Biol. Chem. 282: 26623–26628. [DOI] [PubMed] [Google Scholar]
- Lippman S. I., Broach J. R., 2009. Protein kinase A and TORC1 activate genes for ribosomal biogenesis by inactivating repressors encoded by Dot6 and its homolog Tod6. Proc. Natl. Acad. Sci. USA 106: 19928–19933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loewith R., Hall M. N., 2011. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 189: 1177–1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J. L., et al. , 2002. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10: 457–468. [DOI] [PubMed] [Google Scholar]
- Marion R. M., Regev A., Segal E., Barash Y., Koller D., et al. , 2004. Sfp1 is a stress- and nutrient-sensitive regulator of ribosomal protein gene expression. Proc. Natl. Acad. Sci. USA 101: 14315–14322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin D. E., Soulard A., Hall M. N., 2004. TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1. Cell 119: 969–979. [DOI] [PubMed] [Google Scholar]
- Neklesa T. K., Davis R. W., 2009. A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complex. PLoS Genet. 5: e1000515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Panchaud N., Peli-Gulli M. P., De Virgilio C., 2013. Amino acid deprivation inhibits TORC1 through a GTPase-activating protein complex for the Rag family GTPase Gtr1. Sci. Signal. 6: ra42. [DOI] [PubMed] [Google Scholar]
- Powers T., Walter P., 1999. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae. Mol. Biol. Cell 10: 987–1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reinke A., Anderson S., McCaffery J. M., Yates J., 3rd, Aronova S., et al. , 2004. TOR complex 1 includes a novel component, Tco89p (YPL180w), and cooperates with Ssd1p to maintain cellular integrity in Saccharomyces cerevisiae. J. Biol. Chem. 279: 14752–14762. [DOI] [PubMed] [Google Scholar]
- Sancak Y., Peterson T. R., Shaul Y. D., Lindquist R. A., Thoreen C. C., et al. , 2008. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320: 1496–1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schawalder S. B., Kabani M., Howald I., Choudhury U., Werner M., et al. , 2004. Growth-regulated recruitment of the essential yeast ribosomal protein gene activator Ifh1. Nature 432: 1058–1061. [DOI] [PubMed] [Google Scholar]
- Schimmoller F., Riezman H., 1993. Involvement of Ypt7p, a small GTPase, in traffic from late endosome to the vacuole in yeast. J. Cell Sci. 106(Pt 3): 823–830. [DOI] [PubMed] [Google Scholar]
- Shannon P., Markiel A., Ozier O., Baliga N. S., Wang J. T., et al. , 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13: 2498–2504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slattery M. G., Liko D., Heideman W., 2008. Protein kinase A, TOR, and glucose transport control the response to nutrient repletion in Saccharomyces cerevisiae. Eukaryot. Cell 7: 358–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soulard A., Cremonesi A., Moes S., Schutz F., Jeno P., et al. , 2010. The rapamycin-sensitive phosphoproteome reveals that TOR controls protein kinase A toward some but not all substrates. Mol. Biol. Cell 21: 3475–3486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stark C., Breitkreutz B. J., Reguly T., Boucher L., Breitkreutz A., et al. , 2006. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34: D535–D539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takahara T., Maeda T., 2012. Transient sequestration of TORC1 into stress granules during heat stress. Mol. Cell 47: 242–252. [DOI] [PubMed] [Google Scholar]
- Teng X., Dayhoff-Brannigan M., Cheng W. C., Gilbert C. E., Sing C. N., et al. , 2013. Genome-wide consequences of deleting any single gene. Mol. Cell 52: 485–494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Upadhya R., Lee J., Willis I. M., 2002. Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription. Mol. Cell 10: 1489–1494. [DOI] [PubMed] [Google Scholar]
- Urban J., Soulard A., Huber A., Lippman S., Mukhopadhyay D., et al. , 2007. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol. Cell 26: 663–674. [DOI] [PubMed] [Google Scholar]
- Wade J. T., Hall D. B., Struhl K., 2004. The transcription factor Ifh1 is a key regulator of yeast ribosomal protein genes. Nature 432: 1054–1058. [DOI] [PubMed] [Google Scholar]
- Wang S., Tsun Z. Y., Wolfson R. L., Shen K., Wyant G. A., et al. , 2015. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 347: 188–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winzeler E. A., Shoemaker D. D., Astromoff A., Liang H., Anderson K., et al. , 1999. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901–906. [DOI] [PubMed] [Google Scholar]
- Worley J., Luo X., Capaldi A. P., 2013. Inositol pyrophosphates regulate cell growth and the environmental stress response by activating the HDAC Rpd3L. Cell Reports 3: 1476–1482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yan G., Shen X., Jiang Y., 2006. Rapamycin activates Tap42-associated phosphatases by abrogating their association with Tor complex 1. EMBO J. 25: 3546–3555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yan G., Lai Y., Jiang Y., 2012. The TOR complex 1 is a direct target of Rho1 GTPase. Mol. Cell 45: 743–753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zoncu R., Bar-Peled L., Efeyan A., Wang S., Sancak Y., et al. , 2011. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334: 678–683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zurita-Martinez S. A., Cardenas M. E., 2005. Tor and cyclic AMP-protein kinase A: two parallel pathways regulating expression of genes required for cell growth. Eukaryot. Cell 4: 63–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zurita-Martinez S. A., Puria R., Pan X., Boeke J. D., Cardenas M. E., 2007. Efficient Tor signaling requires a functional class C Vps protein complex in Saccharomyces cerevisiae. Genetics 176: 2139–2150. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.